Literature DB >> 2494708

In situ measurement on 10B concentrations and absorbed dose estimations in human malignant melanoma treated by BNCT.

T Kobayashi1, K Kanda, Y Mishima.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2494708

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  4 in total

1.  Potential of alpha-amino alcohol p-boronophenylalaninol as a boron carrier in boron neutron capture therapy, regarding its enantiomers.

Authors:  Shin-Ichiro Masunaga; Koji Ono; Mitsunori Kirihata; Masao Takagaki; Yoshinori Sakurai; Yuko Kinashi; Tooru Kobayashi; Minoru Suzuki; Kenji Nagata; Hideko Nagasawa; Yoshihiro Uto; Hitoshi Hori
Journal:  J Cancer Res Clin Oncol       Date:  2003-01-11       Impact factor: 4.553

2.  Responses of total and quiescent cell populations in solid tumors to boron and gadolinium neutron capture reaction using neutrons with two different energy spectra.

Authors:  S Masunaga; K Ono; Y Sakurai; M Suzuki; M Takagaki; T Kobayashi; Y Kinashi; M Akaboshi
Journal:  Jpn J Cancer Res       Date:  1998-01

3.  Applicability of combination with tirapazamine in boron neutron capture therapy.

Authors:  S Masunaga; K Ono; Y Sakurai; H Hori; T Kobayashi; M Takagaki; M Suzuki; Y Kinashi; M Akaboshi
Journal:  Jpn J Cancer Res       Date:  1998-07

4.  Evaluation of the potential of p-boronophenylalaninol as a boron carrier in boron neutron capture therapy, referring to the effect on intratumor quiescent cells.

Authors:  S I Masunaga; K Ono; M Kirihata; M Takagaki; Y Sakurai; Y Kinashi; T Kobayashi; H Nagasawa; Y Uto; H Hori
Journal:  Jpn J Cancer Res       Date:  2001-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.